Home Reimbursed medicines Enzalutamid
Enzalutamid — maximum prices and reimbursement
The CANAMED catalogue contains 92 medicines with the active substance Enzalutamid, from 9 manufacturers. Below you can see each entry with the brand name, the manufacturer, the maximum retail price, the reimbursement percentage and the prescription status — plus live pharmacy prices, where we track them.
92
CANAMED entries
9
Manufacturers
12305.21
Maximum price (RON)
1
With a reimbursement percentage
In short: for the active substance Enzalutamid there are 92 authorised medicines in the CANAMED catalogue, with a maximum retail price of 12305.21 RON, from 9 manufacturers. For 1 of them the catalogue also records the reimbursement percentage. The maximum price is the legal cap — pharmacies may sell below it, so it is worth comparing the real price before you go. Latest import: 2026-11-03.
Data verified on from public sources (OpenStreetMap, chain websites, ANM/MS) — updated daily.
CANAMED catalogue
All medicines with Enzalutamid
Maximum retail price = the legal selling cap. Sorted by price, lowest first.
| Brand name | Manufacturer | Maximum price | Reimbursement | Prescription |
|---|---|---|---|---|
| XTANDI 40 mg | ASTELLAS PHARMA EUROPE B.V. - OLANDA | 12305.21 RON | 100% · C2 (national programmes) CNAS pays ~12305.21 RON; you ~0.00 RON* |
PRF |
| ENZALUTAMIDA ACCORD 40 mg | ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA | — | not reimbursed | PRF _X0002_ |
| ENZALUTAMIDA ACCORD 40 mg | ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA | — | not reimbursed | PRF _X0002_ |
| ENZALUTAMIDA RHEI 40 mg | PHARMADOX HEALTHCARE LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA RHEI 40 mg | PHARMADOX HEALTHCARE LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA RHEI 40 mg | PHARMADOX HEALTHCARE LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ 40 mg | LEK PHARMACEUTICALS D.D. - SLOVENIA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ 40 mg | LEK PHARMACEUTICALS D.D. - SLOVENIA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ 40 mg | LEK PHARMACEUTICALS D.D. - SLOVENIA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ 40 mg | LEK PHARMACEUTICALS D.D. - SLOVENIA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ 40 mg | LEK PHARMACEUTICALS D.D. - SLOVENIA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ 40 mg | LEK PHARMACEUTICALS D.D. - SLOVENIA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ 40 mg | LEK PHARMACEUTICALS D.D. - SLOVENIA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ 80 mg | LEK PHARMACEUTICALS D.D. - SLOVENIA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ 80 mg | LEK PHARMACEUTICALS D.D. - SLOVENIA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ 80 mg | LEK PHARMACEUTICALS D.D. - SLOVENIA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ 80 mg | LEK PHARMACEUTICALS D.D. - SLOVENIA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ 80 mg | LEK PHARMACEUTICALS D.D. - SLOVENIA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ 80 mg | LEK PHARMACEUTICALS D.D. - SLOVENIA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ 80 mg | LEK PHARMACEUTICALS D.D. - SLOVENIA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ PHARMACEUTICALS 160 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ PHARMACEUTICALS 160 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ PHARMACEUTICALS 160 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ PHARMACEUTICALS 160 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ PHARMACEUTICALS 40 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ PHARMACEUTICALS 40 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ PHARMACEUTICALS 40 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ PHARMACEUTICALS 40 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ PHARMACEUTICALS 80 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ PHARMACEUTICALS 80 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ PHARMACEUTICALS 80 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA SANDOZ PHARMACEUTICALS 80 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA STADA 160 mg | PHAROS MT LTD. - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA STADA 160 mg | PHAROS MT LTD. - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA STADA 160 mg | PHAROS MT LTD. - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA STADA 160 mg | PHAROS MT LTD. - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA STADA 160 mg | PHAROS MT LTD. - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA STADA 160 mg | PHAROS MT LTD. - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA STADA 160 mg | PHAROS MT LTD. - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA STADA 40 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA STADA 40 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA STADA 40 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA STADA 80 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA STADA 80 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA STADA 80 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA TERAPIA 160 mg | TERAPIA S.A. - ROMANIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TERAPIA 160 mg | TERAPIA S.A. - ROMANIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TERAPIA 160 mg | TERAPIA S.A. - ROMANIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TERAPIA 160 mg | TERAPIA S.A. - ROMANIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TERAPIA 160 mg | TERAPIA S.A. - ROMANIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TERAPIA 160 mg | TERAPIA S.A. - ROMANIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TERAPIA 160 mg | TERAPIA S.A. - ROMANIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TERAPIA 160 mg | TERAPIA S.A. - ROMANIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TERAPIA 160 mg | TERAPIA S.A. - ROMANIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TERAPIA 40 mg | TERAPIA S.A. - ROMANIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TERAPIA 40 mg | TERAPIA S.A. - ROMANIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TERAPIA 40 mg | TERAPIA S.A. - ROMANIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TERAPIA 80 mg | TERAPIA S.A. - ROMANIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TERAPIA 80 mg | TERAPIA S.A. - ROMANIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TERAPIA 80 mg | TERAPIA S.A. - ROMANIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TERAPIA 80 mg | TERAPIA S.A. - ROMANIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TERAPIA 80 mg | TERAPIA S.A. - ROMANIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TEVA 40 mg | ACTAVIS INTERNATIONAL LTD. - BULGARIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TEVA 40 mg | ACTAVIS INTERNATIONAL LTD. - BULGARIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TEVA 40 mg | ACTAVIS INTERNATIONAL LTD. - BULGARIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TEVA 40 mg | ACTAVIS INTERNATIONAL LTD. - BULGARIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TEVA 80 mg | ACTAVIS INTERNATIONAL LTD. - BULGARIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TEVA 80 mg | ACTAVIS INTERNATIONAL LTD. - BULGARIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TEVA 80 mg | ACTAVIS INTERNATIONAL LTD. - BULGARIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TEVA 80 mg | ACTAVIS INTERNATIONAL LTD. - BULGARIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TEVA 80 mg | ACTAVIS INTERNATIONAL LTD. - BULGARIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TEVA 80 mg | ACTAVIS INTERNATIONAL LTD. - BULGARIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TEVA 80 mg | ACTAVIS INTERNATIONAL LTD. - BULGARIA | — | not reimbursed | PRF |
| ENZALUTAMIDA TEVA 80 mg | ACTAVIS INTERNATIONAL LTD. - BULGARIA | — | not reimbursed | PRF |
| ENZALUTAMIDA ZENTIVA 40 mg | ACTAVIS INTERNATIONAL LTD - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA ZENTIVA 40 mg | ACTAVIS INTERNATIONAL LTD - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA ZENTIVA 40 mg | ACTAVIS INTERNATIONAL LTD - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA ZENTIVA 40 mg | ACTAVIS INTERNATIONAL LTD - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA ZENTIVA 80 mg | ACTAVIS INTERNATIONAL LTD - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA ZENTIVA 80 mg | ACTAVIS INTERNATIONAL LTD - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA ZENTIVA 80 mg | ACTAVIS INTERNATIONAL LTD - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA ZENTIVA 80 mg | ACTAVIS INTERNATIONAL LTD - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA ZENTIVA 80 mg | ACTAVIS INTERNATIONAL LTD - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA ZENTIVA 80 mg | ACTAVIS INTERNATIONAL LTD - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA ZENTIVA 80 mg | ACTAVIS INTERNATIONAL LTD - MALTA | — | not reimbursed | PRF |
| ENZALUTAMIDA ZENTIVA 80 mg | ACTAVIS INTERNATIONAL LTD - MALTA | — | not reimbursed | PRF |
| TAGANT 40 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| TAGANT 40 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| TAGANT 40 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| TAGANT 80 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| TAGANT 80 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
| TAGANT 80 mg | PHAROS MT LIMITED - MALTA | — | not reimbursed | PRF |
Reimbursement and amounts come from the CNAS nomenclature (SIUI) valid in the current month, for each pack. *What you pay is indicative: the maximum price minus what CNAS pays on the main sublist, for an insured adult. The pharmacy may sell below the maximum price; low-income pensioners, children, pupils and pregnant women may pay less. C1 applies only to the diseases on the list, and C2 within the national programmes.
Prescription status key:
- PRF — With a medical prescription kept by the pharmacy (P-RF)
- PRF _X0002_ — With a medical prescription (PRF _X0002_)
Live pharmacy prices
Products with Enzalutamid in our comparator
Shelf prices collected from the large chains — see on each product page where it is cheapest.
- ENZALUTAMIDA ACCORD 40 mg
- ENZALUTAMIDA ACCORD 40 mg
- ENZALUTAMIDA RHEI 40 mg
- ENZALUTAMIDA RHEI 40 mg
- ENZALUTAMIDA RHEI 40 mg
- ENZALUTAMIDA SANDOZ 40 mg
- ENZALUTAMIDA SANDOZ 40 mg
- ENZALUTAMIDA SANDOZ 40 mg
- ENZALUTAMIDA SANDOZ 40 mg
- ENZALUTAMIDA SANDOZ 40 mg
- ENZALUTAMIDA SANDOZ 40 mg
- ENZALUTAMIDA SANDOZ 40 mg
Good to know
How to read the maximum price
The CANAMED maximum retail price is the legal cap approved by the Ministry of Health — the pharmacy may sell for less, never for more. If the medicine is reimbursed, the sublist percentage (A 90%, B 50%, C1/C2 100%, D 20%) applies to the reference price of the therapeutic group, usually calculated from the cheapest product with the same INN — which is why your contribution can differ from one brand to another, even for the same active substance. The electronic prescription automatically shows the exact amount to pay; for non-prescription shelf prices, use the HartaFarmacii comparator.
CANAMED catalogue
Other active substances in the catalogue
- Edoxaban
- Etoricoxib
- Enoxaparin
- Esomeprazol
- Escitalopram
- Eltrombopag
- Ezetimib
- Eplerenon
- Everolimus
- Enalapril
See also the full list of reimbursed medicines, with an alphabetical index of all active substances.
Frequently asked questions
FAQ · Enzalutamid
-
Is Enzalutamid reimbursed?
Yes. For 1 of the catalogue entries with Enzalutamid we have the reimbursement percentage on record. The percentage depends on the CNAS sublist each product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and applies to the reference price of the therapeutic group, not to the shelf price. Ask the doctor or pharmacist for the exact placement. -
What is the CANAMED maximum price for Enzalutamid?
The maximum retail price (the CANAMED legal cap) for Enzalutamid is 12305.21 RON. It is the cap above which no pharmacy may sell — many sell below it, so it is worth comparing the real price with the HartaFarmacii comparator. -
What percentage of Enzalutamid is reimbursed?
The percentage depends on the CNAS sublist: A 90% (common chronic diseases), B 50% (partial reimbursement), C1 and C2 100% (serious chronic diseases and national programmes), D 20%. The percentage applies to the reference price set by CNAS, not to the shelf price, so you may pay a difference even for a “100% reimbursed” medicine. You can see the exact placement on the electronic prescription. -
How many medicines with Enzalutamid are in the CANAMED catalogue?
The CANAMED catalogue holds 92 authorised medicines with the active substance Enzalutamid — different brand names, strengths and pharmaceutical forms. You will find them all, with maximum price and prescription status, in the table on this page. Latest CANAMED import into the HartaFarmacii database: 2026-11-03.
Before you go